“Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1” Ihtisham Ul Haq Roll No: 13 Subject: Seminar.

Slides:



Advertisements
Similar presentations
A Little More Advanced Biotechnology Tools
Advertisements

Recombinant DNA Technology
Recombinant DNA technology
Genetic Mutations Recombinant DNA Viruses Chapter 22 Nucleic Acids and Protein Synthesis.
Gene Cloning Techniques for gene cloning enable scientists to prepare multiple identical copies of gene-sized pieces of DNA. Most methods for cloning pieces.
Molecular Genetics Introduction to The Structures of DNA and RNA
Combination of Drugs and Drug-Resistant Reverse Transcriptase Results in a Multiplicative Increase of Human Immunodeficiency Virus Type 1 Mutant Frequencies.
7.1 Techniques for Producing and Analyzing DNA SBI4UP MRS. FRANKLIN.
Cloning a DNA segment from lambda bacteriophage Recombinant DNA technology Allows study of the structure & function of a single protein coding gene in.
Construction, Transformation, and Prokaryote Expression of a Fused GFP and Mutant Human IL-13 Gene Sequence Lindsay Venditti, Department of Biological.
Control of microbial growth. Antimicrobial Classes Disinfectants –Products aimed at reducing by at least five powers of 10 (99,999 %) the number of microorganisms/virus.
Gene Technology Chapter 16.
Manufacture of Human Interleukin 13 Protein Using a Prokaryotic Expression System Ryan Rupp, York College of Pennsylvania, Department of Biological Sciences.
1 Genetics Faculty of Agriculture Instructor: Dr. Jihad Abdallah Topic 13:Recombinant DNA Technology.
Recombinant DNA I Basics of molecular cloning Polymerase chain reaction cDNA clones and screening.
How do you identify and clone a gene of interest? Shotgun approach? Is there a better way?
Lycorine, its use to inhibit flavivirus activity through the suppression of viral RNA synthesis. An Anti-Flavivirus Therapeutic Available for license Presented.
DNA Cloning and PCR.
Biological engineering The recombinant DNA technique Recombinant DNA Any DNA molecule formed by joining DNA fragments from different sources. Commonly.
 Isolate a specific gene of interest  Insert into a plasmid  Transfer to bacteria  Grow bacteria to get many copies  Express the protein product 
Library screening Heterologous and homologous gene probes Differential screening Expression library screening.
Genetic Engineering and Biotechnology IB topics PCR and Introduction to DNA Profiling.
Copyright © 2010 Pearson Education, Inc. Lectures prepared by Christine L. Case Chapter 9 Biotechnology and Recombinant DNA.
Plasmids Continued Once we insert the plasmid into the bacteria how do we know its in the bacteria and has the the right gene in it?
Determining if the fused product of Botox A and GFP can be used to observe the binding patterns of Botulinum toxin A. Felicia Yothers Department of Biological.
PHARMACOBIOTECHNOLOGY.  Recombinant DNA (rDNA) is constructed outside the living cell using enzymes called “restriction enzymes” to cut DNA at specific.
Confirmation of positive clones Screening of positive clones Selection of high copy number clones Selection of positive clones FLUTCORE vaccine yeast constructs.
Concept 20.1: DNA cloning yields multiple copies of a gene or other DNA segment To work directly with specific genes, scientists prepare well-defined segments.
Studying the genomes of organisms GENE TECHNOLOGY.
Chapter 20: DNA Technology and Genomics - Lots of different techniques - Many used in combination with each other - Uses information from every chapter.
Plasmids and Vectors Aims:
8.1 - Manipulating & Cloning DNA
Genetic Engineering/ Recombinant DNA Technology
DNA Technology & Genomics
A Molecular Toolkit AP Biology Fall The Scissors: Restriction Enzymes  Bacteria possess restriction enzymes whose usual function is to cut apart.
Figure S1. Production of recombinant NS1 protein
4/26/2010 BIOTECHNOLOGY.
Figure 1. Analysis of truncated-UL13 protein prokaryotic expression and UL13 expression in DEV-infected DEF cells. (A) Expression and purification of the.
(Journal of Biomedical and Clinical Sciences)
Gene Cloning Techniques for gene cloning enable scientists to prepare multiple identical copies of gene-sized pieces of DNA. Most methods for cloning pieces.
Ahangarzadeh, Sh. *1 Bandehpour, M.1, Kazemi, B.1 , Yarian, F.1
Comparative genotypic and phenotypic characterization of
CHAPTER 20 PART 3: A LITTLE MORE ADVANCED BIOTECHNOLOGY TOOLS
Genetic Research and Biotechnology Recombinant technology
A flavone-based inhibitor of in vitro human rhinovirus replication induces resistant mutations in capsid protein VP4. Céline Lacroixa, Hari Babu Bollikollac,
Autophagy reduces Semliki Forest virus replication in neuronal cells
GENETIC ENGINEERING College of Science/ biology department
Chapter 20: DNA Technology and Genomics
Dr T-J’s Minilecture Chapter 12.
Genetic Research and Biotechnology Recombinant technology
Molecular Cloning.
Volume 19, Issue 6, Pages (June 2016)
How are areas of DNA that don’t code for proteins (genes) used by our cells? How can we make use of these areas?
A Little More Advanced Biotechnology Tools
Recombinant DNA Technology
Kazuyuki Nakagome, MD, PhD, Yury A
Volume 21, Issue 11, Pages (December 2017)
Emerging Therapeutic Targets for Hepatitis C Virus Infection
Volume 21, Issue 2, Pages (February 2014)
Volume 18, Issue 11, Pages (November 2011)
B Cell Receptor Activation and Chemical Induction Trigger Caspase-Mediated Cleavage of PIAS1 to Facilitate Epstein-Barr Virus Reactivation  Kun Zhang,
A Little More Advanced Biotechnology Tools
Components and Dynamics of DNA Replication Complexes in S
Volume 26, Issue 4, Pages (April 2018)
Volume 35, Issue 4, Pages (August 2002)
B. subtilis GS67 Protects C
Chapter 20: DNA Technology and Genomics
Regulation of human renin gene promoter activity: A new negative regulatory region determines the responsiveness to TNFα  Ling-Sing K. Chen, Michael P.
Volume 26, Issue 3, Pages e3 (January 2019)
Cloning a DNA segment from lambda bacteriophage
Presentation transcript:

“Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1” Ihtisham Ul Haq Roll No: 13 Subject: Seminar 5 th Semester, Department of Microbiology Abdul Wali Khan University Mardan

Introduction The dengue virus – a flavivirus of which there are four serotypes. Dengue is widespread in tropical and subtropical regions of central and South America and south and south-east Asia. They translates on the host cell ribosomal machinery to produce polypeptide. NS3 protein is one of the most important non-structural proteins. The activity of NS3pro is depends on the interaction with NS2B protein to form NS2B-NS3pro. NS2B-NS3pro is considered as potential target for antiviral drug design. Retrocyclin-1 is disulphide cyclic peptide which has significantly inhibitory potential against Dengue NS2B-NS3pro.

Construction of plasmids pQE30-NS2BNS3pro Mosquito cell line C6/36 infected with DEN-2 viruses and incubated at 32°C for 3 days. For amplification cDNA fragments of NS2B-NS3pro, viral RNA was extracted using viral RNA Extraction Kit based onto the manufacturer’s instructions The cDNA fragments was generated using NS2BF and NS3R. These sequences then used as template to amplify NS2B and NS3pro by PCR reactions The linker sequence and KpnI restriction sites were added to NS2BlikR and NS3likR primers. The PCR products were subsequently digested with BamHI and KpnI. The purified fragments were cloned into pQE30 plasmid downstream of the 6XHis tag.

Protein production in E.coli

Antimicrobial activity of RC-1 The disc diffusion susceptibility test was used to evaluate antimicrobial activity of the recombinant RC-1. The samples of recombinant RC-1 were dropped onto a filter paper discs (0.1 mg/ml). Then, the filter paper discs placed on E.coli inoculated MH agar and Saccharomyces cerevisiae inoculated YPD agar plates. Both inoculated plates were inoculated for 16 hrs at 35°C and 30°C, respectively.

Treatment of DENV-2 infected cells with recombinant RC-1 Three independent experiments were carried out with RC-1 at 24, 48 and 72 hrs of each infection in triplicates which is:  Pre-infection treatment  Simultaneous infection treatment  Post-infection treatment Vero cells were grown in a 24-well tissue culture plate (1×105 cells/well). Incubated for 24 hrs under optimal conditions and infected with DENV-2.

Result: The inhibitory potential of RC-1 against Dengue protease The ability of NS2B-NS3pro to cleave the fluorogenic peptide substrate was variable at different temperatures  Highest activity at 28°C  Lowest activity at 40°C  Midrange activity at 37°C The inhibition profile of RC-1 was variable at different temperatures  At 28°C, RC-1 exhibited 100% inhibition of NS2B-NS3pro at concentration of 120 μM  Complete inhibition was observed at 100 μM and 37.5 μM at 37°C and 40 °C  The lowest 50% inhibitory concentration (IC50 value) of RC-1 was observed at 40°C (14.1 ± 1.2 μM) and the highest IC50 at 28°C (46.1 ±1.7 μM) whilst at 37°C, the IC50 of RC-1 was 21.4 ± 1.6 μM.

The inhibitory potential of RC-1 against dengue virus replication in Vero cells The maximum non-toxic dose (MNTD) of RC-1 concentration in Vero cells was found to be 150 μM for all of the three incubation periods, 24, 48 and 72 hrs. RNA of DENV-2 was extracted from RC-1 treated and control cells and quantified by real-time PCR. The results showed that the highest percentage of reduction in total viral RNA copies was observed for the simultaneous treatment modes as compared to pre and post treatment modes.

Conclusion We successfully produced bioactive recombinant RC-1 in E. coli as a cost-effective expression system that can be developed for large-scale production. The recombinant RC-1 was able to inhibit dengue protease that led to reduction of dengue virus in Vero cells. These findings may have its importance in the development of therapeutic agent especially against dengue infection.